standard-title Complaints and returns
Latest News on Your Doctor's Blog
In Pleven, at Corona Restaurant on May 30, 2018 at 7:00 pm a round table was held with a presentation on the topic of rhinitis – differential diagnosis and new therapeutic options. Restive – Natural Histamine Blocker for Rapid Allergy Relief, Presentation Lecturer Assoc. Prof. Dr. Kutsarov, MD Otolaryngologist, Medical University – Varna. The event was attended by over 34 pediatrician and pediatric general practitioners as well as ENT specialists. .
From March 15, 2019 to March 17, 2019, the 5th Veliko Tarnovo National Pediatric Conference was held at Hotel Sevastokrator, Arbanassi, in which Bioshild Ltd. participated. The forum was attended by more than 250 pediatricians and practitioners from all over the country – Sofia, Ruse, Plovdiv, Burgas, Silistra, Veliko Turnovo, Pleven, Lovech, Gabrovo and others.
From May 23 to May 26, 2019 at the Majestic Hotel Sunny Beach was held the 20th Anniversary National Conference for GPs and Pediatricians with international participation, in which the company Bioshield Ltd. participated included 500 delegates and 58 pharma companies were registered. The interest in the booth of Bioshield Ltd. was great, with the focus on the company’s new products: Cavisept 3% NaCL-hypertonic solution for inhalation and intranasal administration and Restive-natural histamine blocker.
Sourse : https://www.ncbi.nlm.nih.gov/pubmed/17456621 Prevention of influenza episodes with colostrum compared with vaccination in healthy and at-risk patients with cardiovascular disease: Epidemiological study in San Valentino, Pescara, Italy. The effectiveness of 2-month colostrum intake in the prevention of influenza compared to influenza vaccination is evaluated. The groups include healthy individuals and those receiving vaccination and colostrum. After 3 months of monitoring, the number of sick days was 3 times higher in patients who have not taken colostrum. The colostrum group had 13 episodes versus 14 in the colostrum + vaccination group, 41 in the non-prophylaxis group, and 57 in patients who did not take anything. Part 2 of the study has a similar protocol with 65 high-risk cardiovascular patients, all of whom have underwent prophylactic examinations.The incidence of complications and hospitalization was higher in the vaccine-only group than in the colostrum-treated group. Conclusion: Colostrum, both in healthy individuals and in patients at high risk of cardiovascular disease, is at least 3 times more effective than influenza vaccination and is also very cost effective.
The activity of the company is closely related to the production of tested functional nutritional supplements and cosmetic products with close dermatological application.